Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Pravastatin Reduces Risk of Stroke: Prof. Sacks of Harvard
February 11, 2002
- Amrubicin, Gatifloxacin Recommended for Approval
February 11, 2002
- Efficient Drug Development Expected with Human Tissue Bank: JHSF
February 11, 2002
- Korosho Considers Issuing Its Own List of Essential Drugs
February 11, 2002
- WORLD NEWS IN BRIEF
February 11, 2002
- Number of Births Continues to Decrease
February 11, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 11, 2002
- Pharmacoeconomic Data Not Reflected in NHI Pricing: Expert
February 11, 2002
- Kyu-Yu-Kai, Efco to Merge in April
February 11, 2002
- Survey Shows Marked Decreases in People's Interest in Science
February 11, 2002
- P&G to Sell Vicks Medicated Drop Business
February 11, 2002
- REGULATORY NEWS IN BRIEF
February 11, 2002
- Olympus Develops DNA Computer for Gene Analysis
February 11, 2002
- Yamanouchi, Sumitomo Chemical Tie Up on Knockout Mice with Transgenic Inc
February 11, 2002
- Eiken Develops New Bovine Embryo Sexing Reagent
February 11, 2002
- Tanabe Ties Up with Menarini to Develop Antitumor Agent
February 11, 2002
- BML to Merge 2 Subsidiaries
February 11, 2002
- Sanuki, Ohmori Yakuhin Shikoku, Baikado to Form Koyo on April 1
February 4, 2002
- Daiwa, Kowa to Tie Up in Shikoku
February 4, 2002
- Medical Fee Reduction to Seriously Hit Medical Institutions: JMARI
February 4, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…